Molecular Cancer Therapeutics CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tong, Y.
Right arrow Articles by Gourdeau, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tong, Y.
Right arrow Articles by Gourdeau, H.
Vol. 1, 95-102, December 2001     Molecular Cancer Therapeutics
© 2001 American Association for Cancer Research

The Pro-apoptotic Protein, Bik, Exhibits Potent Antitumor Activity That Is Dependent on Its BH3 Domain1

Yiai Tong, Quan Yang, Carol Vater, L.K. Venkatesh, Dominique Custeau, Thomas Chittenden, G. Chinnadurai and Henriette Gourdeau2

Shire BioChem, Inc., Laval, Québec, H7V 4A7 Canada [Y. T., Q. Y., D. C., H. G.]; The Institute for Molecular Virology, St. Louis University Medical Center, St. Louis, Missouri 63110 [L. K. V., G. C.]; and Apoptosis Technology, Inc., Cambridge, Massachusetts 02139 [C. V., T. C.]

The Bcl-2 homology 3 (BH3) domain is present in most members of the Bcl-2 protein family and is required to confer the death-inducing properties of pro-apoptotic members, including Bax, Bak, Bad, and Bik, in cell-based assay systems. To determine whether the BH3 domain possesses a similar role in tumor tissues in vivo, we overexpressed the wild-type Bik protein and its BH3-deleted counterpart, using adenoviral technology, in chemoresistant human tumor prostate (PC-3) and colon (HT-29) cell lines growing in vitro and in vivo. Bik caused apoptosis in both PC-3 and HT-29 cells in vitro by inducing the release of cytochrome c from mitochondria to cytoplasm, resulting in the catalytic activation of caspases 9, 7, and 3 and cleavage of poly(ADP-ribose) polymerase and DNA fragmentation. When the BH3 domain was deleted from the Bik protein, no effect on mitochondrial activity or cell morphology could be observed. Furthermore, intratumoral injection of an adenovirus vector expressing the Bik gene, but not the deleted BH3 Bik gene, suppressed the growth of PC-3 and HT-29 xenografts established in nude mice. Histological examination of tumors from mice treated with the wild-type Bik adenoviral construct demonstrated cellular debris, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling positive staining, and morphological changes associated with apoptosis. In contrast, tissue sections obtained from tumors treated with the BH3-deleted Bik adenoviral construct showed no evidence of apoptosis. Thus, our results suggest that the BH3 domain is required for the antitumor activity of the Bik protein and provides a novel therapeutic approach for cancer therapy.




This article has been cited by other articles:


Home page
JCBHome page
B. Gillissen, F. Essmann, P. G. Hemmati, A. Richter, A. Richter, I. Oztop, G. Chinnadurai, B. Dorken, and P. T. Daniel
Mcl-1 determines the Bax dependency of Nbk/Bik-induced apoptosis
J. Cell Biol., November 19, 2007; 179(4): 701 - 715.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T.-Y. Kim, S. Zhong, C. R. Fields, J. H. Kim, and K. D. Robertson
Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.
Cancer Res., August 1, 2006; 66(15): 7490 - 7501.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. Tesfaigzi
Roles of Apoptosis in Airway Epithelia
Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 537 - 547.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
S. Yui, T. Saeki, R. Kanamoto, and K. Iwami
Characteristics of Apoptosis in HCT116 Colon Cancer Cells Induced by Deoxycholic Acid
J. Biochem., August 1, 2005; 138(2): 151 - 157.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Hur, J. Chesnes, K. R. Coser, R. S. Lee, P. Geck, K. J. Isselbacher, and T. Shioda
The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis
PNAS, February 24, 2004; 101(8): 2351 - 2356.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. J. Wilson, D. Arango, J. M. Mariadason, B. G. Heerdt, and L. H. Augenlicht
TR3/Nur77 in Colon Cancer Cell Apoptosis
Cancer Res., September 1, 2003; 63(17): 5401 - 5407.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Milutinovic, Q. Zhuang, A. Niveleau, and M. Szyf
Epigenomic Stress Response. KNOCKDOWN OF DNA METHYLTRANSFERASE 1 TRIGGERS AN INTRA-S-PHASE ARREST OF DNA REPLICATION AND INDUCTION OF STRESS RESPONSE GENES
J. Biol. Chem., April 18, 2003; 278(17): 14985 - 14995.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Theodorakis, E. Lomonosova, and G. Chinnadurai
Critical Requirement of BAX for Manifestation of Apoptosis Induced by Multiple Stimuli in Human Epithelial Cancer Cells
Cancer Res., June 1, 2002; 62(12): 3373 - 3376.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.